Impact of platelet-rich plasma on an ovary in cases of poor ovarian functio
Phase 3
Recruiting
- Conditions
- Poor Ovarian Response.Female infertility
- Registration Number
- IRCT20210828052310N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 12
Inclusion Criteria
History of less than 3 eggs per cycle
Antimullerian hormone less than 0.5
Antral follicles less than 5
Existence of 10 million sperm in sperm analysis
At least three percent of normal sperm morphology
Exclusion Criteria
Immunological diseases of patients
Hematologic disease
Chromosomal or genetic disorder
Hemoglobin level less than 11 grams per deciliter and platelets less than one hundred and fifty thousand per cubic millimeter
Systemic use of corticosteroids within two weeks before the procedure
Absence of underlying disease of infertile women
No contraindications for pregnancy
Uterine disorders
Submucosal myoma
Asherman syndrome
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of Oocyte in the first and second cycles. Timepoint: The oocyte retrieval day. Method of measurement: Based on embryologist assessment.;Number of mature oocyte. Timepoint: The oocyte retrieval day in the first and second cycles. Method of measurement: Based on embryologist assessment.;Anti Mullerian Hormone level. Timepoint: The second day of cycles 1 and 2. Method of measurement: Blood test.;Follicle Stimulating Hormone level. Timepoint: The second day of cycles 1 and 2. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method umber of Embryo. Timepoint: Three to six days after fertilization. Method of measurement: Based on the opinion of the embryologist.